Spots Global Cancer Trial Database for A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer
Official Title: A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors
Study ID: NCT04586270
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tennessee Oncology, Nashville, Tennessee, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Centre de Lutte Contre le Cancer Gustave Roussy, Villejuif, Val De Marne, France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
